Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Apr 19;104(11):1755–1761. doi: 10.1038/bjc.2011.132

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2011 Cancer Research UK

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Phosphorylation of Akt on Thr308 in NSCLC tumour tissue in comparison with patient-matched normal lung tissue. Triplicate samples of lysate from patient-matched normal (N1–3) and tumour (T1–3) tissues were separated on SDS–PAGE gels. Phosphorylation of Akt on Thr308 was determined by western blotting with a pAkt-Thr308 antibody followed by quantitation by densitometric scanning. (A) Quantified data for all 29 patients. Each bar represents the average phosphorylation for normal (N1–3; light grey) or tumour (T1–3; black) tissue for each patient (mean±s.e.m.). The strength of evidence for a difference in phosphorylation between the normal and tumour samples was determined by Kruskal–Wallis test; ^*P<0.05. (B) The percentage change in Akt-Thr308 phosphorylation in tumour samples in comparison with patient-matched normal tissue where patients are ranked in order of the extent of the percentage change in phosphorylation.